CEO and Founder, Empiriko: Pam Randhawa has over 15 years of experience in the healthcare and life sciences industries. Having worked in strategy, product management, consulting and marketing, her specialized knowledge of market analysis, strategic planning, business development and product management enables her to successfully guide new product evolution and strategic development. In her current role as CEO and Founder of Empiriko, Ms. Randhawa is working to develop a Clinical-Intelligent Technology platform and applications that bridge information gaps throughout the drug development life cycle and continuously learn and leverage knowledge from experiential data and patient outcomes.

Prior to founding Empiriko, she served as VP of Strategic Development at Sermo, where she was responsible for identifying and developing new markets in the areas of clinical development, analytics and international expansion. Prior to joining Sermo, Ms. Randhawa served as VP of Marketing at Phase Forward, where she was responsible for the planning and execution of the company's global marketing strategy. Previously, Ms. Randhawa held senior roles at McKesson Corporation where she effectively leveraged healthcare longitudinal data to advise managed care companies in assessing the effectiveness of various therapies, reducing healthcare costs, and ensuring the quality of care provided to healthcare plan members. She also served as an independent consultant to the State of Ohio, Department of Health, where she led a statewide taskforce for the Health Status of Ohioans for the State Health Plan.

Ms. Randhawa currently serves on the Advisory Boards of Cognika, a provider of machine learning and advanced analytical software solutions, and GlobalCures, a nonprofit pharmaceutical organization focusing on cancer therapies. She holds a Bachelors Degree in economics from the University of Rajasthan, India, and a Masters Degree in public management from Carnegie Mellon University. She served on the MIT blackjack team as a player (cardcounter) and an investor.